In the past week, PFE stock has gone up by 1.24%, with a monthly gain of 3.95% and a quarterly plunge of -5.75%. The volatility ratio for the week is 1.61%, and the volatility levels for the last 30 days are 1.84% for Pfizer Inc The simple moving average for the last 20 days is 3.01% for PFE stock, with a simple moving average of -2.24% for the last 200 days.
Is It Worth Investing in Pfizer Inc (PFE) Right Now?
Moreover, the 36-month beta value for PFE is 0.29. Analysts have varying opinions on the stock, with 9 analysts rating it as a “buy”, 2 as “overweight”, 16 as “hold”, and 1 as “sell”.
The public float for PFE is 5.69B and currently, short sellers hold a 2.88% of that float. On July 29, 2026, PFE’s average trading volume was 41.29M shares.
PFE stock’s latest price update
Pfizer Inc (PFE) has seen a rise in its stock price by 2.35% in relation to its previous close of $24.67. However, the company has experienced a 1.24% gain in its stock price over the last five trading sessions. zacks.com reported 2026-07-28 that In the most recent trading session, Pfizer (PFE) closed at $25.25, indicating a +2.35% shift from the previous trading day.
Analysts’ Opinion of PFE
Many brokerage firms have already submitted their reports for PFE stocks, with HSBC Securities repeating the rating for PFE by listing it as a “Hold”. The predicted price for PFE in the upcoming period, according to HSBC Securities is $28 based on the research report published on July 06, 2026 of the current year 2026.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see PFE reach a price target of $25. The rating they have provided for PFE stocks is “Sector Perform” according to the report published on June 10th, 2026.
RBC Capital Mkts gave a rating of “Underperform” to PFE, setting the target price at $25 in the report published on February 25th of the current year.
PFE Trading at 0.56% from the 50-Day Moving Average
After a stumble in the market that brought PFE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.16% of loss for the given period.
Volatility was left at 1.84%, however, over the last 30 days, the volatility rate increased by 1.61%.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PFE starting from DAMICO JENNIFER B., who sold 2,000 shares at the price of $25.70 back on Jun 09 ’26. After this action, DAMICO JENNIFER B. now owns 31,397 shares of Pfizer Inc, valued at $51,400 using the latest closing price.
Stock Fundamentals for PFE
Current profitability levels for the company are sitting at:
- 0.23% for the present operating margin
- 0.69% for the gross margin
The net margin for Pfizer Inc stands at 0.12%. The total capital return value is set at 0.09%. Equity return is now at value 8.29%, with 3.60% for asset returns.
Based on Pfizer Inc (PFE), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 0.72. The interest coverage ratio of the stock is 5.53.
Currently, EBITDA for the company is $15.1 billion with net debt to EBITDA at 3.75. When we switch over and look at the enterprise to sales, we see a ratio of 3.26. The receivables turnover for the company is 5.03for trailing twelve months and the total asset turnover is 0.3. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.25.
Conclusion
To wrap up, the performance of Pfizer Inc (PFE) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
